跳至主要内容
临床试验/NCT01171521
NCT01171521终止不适用

Management of Complex Wounds Using a Constant Tension External Tissue Expander

University of Missouri-Columbia2 个研究点 分布在 1 个国家目标入组 6 人开始时间: 2010年7月最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
6
试验地点
2
主要终点
Quality of Life

研究概览

简要总结

Complex wounds that cannot be closed primarily are at great risk for complications. A new technique utilizing external tissue expansion holds promise in rapidly decreasing wound area. Facilitation of rapid wound closure is critical in preventing wound complications.

Hypothesis:

Using the Dermaclose Wound Management System (Woundcare Technologies, Inc., Chanhassen, MN) in complex wounds not able to be primarily closed will decrease the time to secondary closure and decrease the need for secondary soft tissue coverage procedures, or if secondary soft tissue procedures are required, its use will decrease the size and complexity of the secondary soft tissue procedures.

Null Hypothesis:

The Dermaclose system will not decrease the need, dimensions, or complexity of secondary soft tissue coverage procedures in complex wounds not able to be primarily closed.

详细描述

Upon IRB approval, 50 patients with complex soft tissue wounds, with or without an associated fracture that cannot be closed primarily will have the Dermaclose device applied and will be prospectively followed for 1 year. The Dermaclose device will be applied according to the manufacturer's guidelines. This device may be combined with the use of Negative Pressure Wound Therapy. Primary and secondary end points that were initially intended to be included are listed below. However, on SF12 and pain outcome measures were collected and reported.

Initially Intended Primary end points (only SF12 collected and reported):

SF12

  1. Initial and final wound dimensions
  2. Secondary soft tissue coverage procedures
  3. Dimensions and type of secondary soft tissue coverage procedures required compared to initial wound dimensions
  4. Method of wound closure
  5. Days to wound closure
  6. Number and types of procedures required for wound closure
  7. Infection requiring reoperation
  8. Wound dehiscence requiring reoperation

Initially intended Secondary end points (only #3 collected and reported):

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 18 or greater
  • Has soft tissue wound(s) that are unable to be closed primarily

排除标准

  • Age less than 18
  • Has wound(s) that can be closed primarily
  • Infected wound
  • Unable to comply with protocol
  • Prior radiation treatment to skin or soft tissues in the area of the wound
  • Friable wound margins

结局指标

主要结局

Quality of Life

时间窗: 6 months

The SF-12 contains 12 items from the SF-36 Health Survey - . The SF-12 contains one or two items that measure each of the eight concepts included in the SF-36. The Quality of Life SF-12 is a scale from 0 - 100, in which 0 = poor functioning and 100 = excellent functioning.

次要结局

  • Pain(6 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Brett Crist

Assistant Professor, Co-Director of Trauma Services, Co-Director Trauma Fellowship, Department of Orthopaedic Surgery

University of Missouri-Columbia

研究点 (2)

Loading locations...

相似试验